drugset / Trial / NCT02650063
A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -
NaSingle-groupOpen-labelBasic science
Summary
The purposes of this study are to evaluate the safety and plasma pharmacokinetics of DE-117 ophthalmic solution (one drop once daily for 7 days) in healthy male adults.
Timeline
- Start
- 2015-12
- Primary completion
- 2016-02
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | omidenepag isopropyl | Small molecule | — | Other |
Indications
No indication recorded.